Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.11
MDRX's Cash to Debt is ranked lower than
65% of the 1620 Companies
in the Global Health Information Services industry.

( Industry Median: 27.13 vs. MDRX: 0.11 )
MDRX' s 10-Year Cash to Debt Range
Min: 0.11   Max: No Debt
Current: 0.11

Equity to Asset 0.50
MDRX's Equity to Asset is ranked higher than
55% of the 1591 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. MDRX: 0.50 )
MDRX' s 10-Year Equity to Asset Range
Min: 0.3   Max: 0.95
Current: 0.5

0.3
0.95
F-Score: 3
Z-Score: 1.62
M-Score: -2.76
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) -9.29
MDRX's Operating margin (%) is ranked lower than
55% of the 1594 Companies
in the Global Health Information Services industry.

( Industry Median: 5.57 vs. MDRX: -9.29 )
MDRX' s 10-Year Operating margin (%) Range
Min: -666.68   Max: 14.84
Current: -9.29

-666.68
14.84
Net-margin (%) -7.58
MDRX's Net-margin (%) is ranked lower than
54% of the 1592 Companies
in the Global Health Information Services industry.

( Industry Median: 3.70 vs. MDRX: -7.58 )
MDRX' s 10-Year Net-margin (%) Range
Min: -590.73   Max: 8.92
Current: -7.58

-590.73
8.92
ROE (%) -7.89
MDRX's ROE (%) is ranked lower than
53% of the 1553 Companies
in the Global Health Information Services industry.

( Industry Median: 6.88 vs. MDRX: -7.89 )
MDRX' s 10-Year ROE (%) Range
Min: -424.73   Max: 9.87
Current: -7.89

-424.73
9.87
ROA (%) -3.97
MDRX's ROA (%) is ranked lower than
52% of the 1605 Companies
in the Global Health Information Services industry.

( Industry Median: 3.73 vs. MDRX: -3.97 )
MDRX' s 10-Year ROA (%) Range
Min: -356.71   Max: 5.74
Current: -3.97

-356.71
5.74
ROC (Joel Greenblatt) (%) -73.33
MDRX's ROC (Joel Greenblatt) (%) is ranked lower than
57% of the 1589 Companies
in the Global Health Information Services industry.

( Industry Median: 31.80 vs. MDRX: -73.33 )
MDRX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -3298.37   Max: 335.02
Current: -73.33

-3298.37
335.02
Revenue Growth (%) 17.80
MDRX's Revenue Growth (%) is ranked higher than
88% of the 1208 Companies
in the Global Health Information Services industry.

( Industry Median: 6.40 vs. MDRX: 17.80 )
MDRX' s 10-Year Revenue Growth (%) Range
Min: -28.7   Max: 24.4
Current: 17.8

-28.7
24.4
EBITDA Growth (%) -29.90
MDRX's EBITDA Growth (%) is ranked lower than
53% of the 957 Companies
in the Global Health Information Services industry.

( Industry Median: 7.60 vs. MDRX: -29.90 )
MDRX' s 10-Year EBITDA Growth (%) Range
Min: -67.6   Max: 105.3
Current: -29.9

-67.6
105.3
» MDRX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

MDRX Guru Trades in Q1 2013

Chuck Royce 730,300 sh (New)
RS Investment Management 4,150,202 sh (+134.2%)
Vanguard Health Care Fund 4,007,209 sh (+5.81%)
Michael Price 477,500 sh (unchged)
Paul Tudor Jones Sold Out
Manning & Napier Advisors, Inc Sold Out
Jim Simons Sold Out
Third Avenue Management 1,171,137 sh (-5.21%)
Joel Greenblatt 39,601 sh (-12.89%)
Steven Cohen 444,625 sh (-58.23%)
» More
Q2 2013

MDRX Guru Trades in Q2 2013

Columbia Wanger 6,996,000 sh (New)
Vanguard Health Care Fund 8,351,463 sh (+108.41%)
Chuck Royce 996,300 sh (+36.42%)
RS Investment Management 4,180,137 sh (+0.72%)
Michael Price 477,500 sh (unchged)
Stanley Druckenmiller Sold Out
Third Avenue Management 1,131,137 sh (-3.42%)
Joel Greenblatt 22,394 sh (-43.45%)
Steven Cohen 116,406 sh (-73.82%)
» More
Q3 2013

MDRX Guru Trades in Q3 2013

Columbia Wanger 12,543,700 sh (+79.3%)
Third Avenue Management 1,380,244 sh (+22.02%)
Chuck Royce 1,069,300 sh (+7.33%)
Vanguard Health Care Fund 8,542,653 sh (+2.29%)
Michael Price 477,500 sh (unchged)
RS Investment Management 4,178,052 sh (-0.05%)
Steven Cohen 114,713 sh (-1.45%)
Joel Greenblatt 17,732 sh (-20.82%)
» More
Q4 2013

MDRX Guru Trades in Q4 2013

Jim Simons 19,965 sh (New)
RS Investment Management 5,829,716 sh (+39.53%)
Chuck Royce 1,242,300 sh (+16.18%)
Third Avenue Management 1,535,465 sh (+11.25%)
Steven Cohen 124,794 sh (+8.79%)
Columbia Wanger 12,543,700 sh (unchged)
Vanguard Health Care Fund 8,542,653 sh (unchged)
Michael Price 477,500 sh (unchged)
Joel Greenblatt Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with MDRX

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-12-31 Sold Out 0.01%$13.83 - $15.38 $ 16.6113%0
Joel Greenblatt 2013-09-30 Reduce -20.82%$13.12 - $16.26 $ 16.6110%17732
Vanguard Health Care Fund 2013-06-30 Add 108.41%0.21%$12.58 - $14.09 $ 16.6124%8351463
Joel Greenblatt 2013-06-30 Reduce -43.45%0.01%$12.58 - $14.09 $ 16.6124%22394
Joel Greenblatt 2012-12-31 Reduce -44.58%0.03%$9.08 - $13.9 $ 16.6137%45460
Vanguard Health Care Fund 2012-12-31 Add 55.24%0.03%$9.08 - $13.9 $ 16.6137%3787009
Joel Greenblatt 2012-09-30 Reduce -31.85%0.03%$8.99 - $12.42 $ 16.6159%82022
Michael Price 2012-06-30 New Buy0.63%$9.41 - $16.69 $ 16.6135%400000
Vanguard Health Care Fund 2012-06-30 New Buy0.13%$9.41 - $16.69 $ 16.6135%2439400
Ron Baron 2012-06-30 Sold Out 0.13%$9.41 - $16.69 $ 16.6135%0
Joel Greenblatt 2012-06-30 Add 442.49%0.08%$9.41 - $16.69 $ 16.6135%120363
Ron Baron 2012-03-31 Reduce -20.47%0.04%$16.68 - $21.47 $ 16.61-7%1305220
Joel Greenblatt 2012-03-31 New Buy0.03%$16.68 - $21.47 $ 16.61-7%22187
George Soros 2011-06-30 Sold Out $18.48 - $22.71 $ 16.61-18%0
George Soros 2011-03-31 Reduce -52.59%$19.27 - $22.185 $ 16.61-20%11000
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Allscripts Healthcare Solutions Inc

Columbia Management's Top 5 New Buys with Positive Outlook
As one of the 10 largest management firms in the U.S., Columbia Management Investment Advisers oversees $300 billion in a variety of mutual funds, closed-end funds and other products. The firm announced 24 new stock positions made in the second quarter, bringing about a 5% turnover in its portfolio totaling 310 stocks. Read more...

Ratios

vs
industry
vs
history
P/B 2.25
MDRX's P/B is ranked higher than
64% of the 1505 Companies
in the Global Health Information Services industry.

( Industry Median: 2.45 vs. MDRX: 2.25 )
MDRX' s 10-Year P/B Range
Min: 0.79   Max: 8.74
Current: 2.25

0.79
8.74
P/S 2.14
MDRX's P/S is ranked higher than
52% of the 1660 Companies
in the Global Health Information Services industry.

( Industry Median: 2.00 vs. MDRX: 2.14 )
MDRX' s 10-Year P/S Range
Min: 0.91   Max: 7.12
Current: 2.14

0.91
7.12
Shiller P/E 153.85
MDRX's Shiller P/E is ranked lower than
73% of the 617 Companies
in the Global Health Information Services industry.

( Industry Median: 29.33 vs. MDRX: 153.85 )
MDRX' s 10-Year Shiller P/E Range
Min: 29.45   Max: 400.8
Current: 153.85

29.45
400.8

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.63
MDRX's Price/DCF (Projected) is ranked higher than
58% of the 743 Companies
in the Global Health Information Services industry.

( Industry Median: 1.50 vs. MDRX: 1.63 )
MDRX' s 10-Year Price/DCF (Projected) Range
Min: 0.86   Max: 6.76
Current: 1.63

0.86
6.76
Price/Median PS Value 0.60
MDRX's Price/Median PS Value is ranked higher than
90% of the 1501 Companies
in the Global Health Information Services industry.

( Industry Median: 1.10 vs. MDRX: 0.60 )
MDRX' s 10-Year Price/Median PS Value Range
Min: 0.33   Max: 6.84
Current: 0.6

0.33
6.84
Earnings Yield (Greenblatt) 0.50
MDRX's Earnings Yield (Greenblatt) is ranked lower than
72% of the 1328 Companies
in the Global Health Information Services industry.

( Industry Median: 5.40 vs. MDRX: 0.50 )
MDRX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 5.8
Current: 0.5

0.1
5.8
Forward Rate of Return (Yacktman) -0.11
MDRX's Forward Rate of Return (Yacktman) is ranked higher than
62% of the 1009 Companies
in the Global Health Information Services industry.

( Industry Median: 5.44 vs. MDRX: -0.11 )
MDRX' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -10.4   Max: 69.4
Current: -0.11

-10.4
69.4

Business Description

Industry: Application Software » Health Information Services
Compare:CERN, CTRX, ATHN, AH, QSII » details
Traded in other countries:AL21.Germany
Allscripts Healthcare Solutions Inc is a provider of clinical, financial, connectivity and information solutions and related professional services that empower hospitals, physicians and post-acute organizations to deliver world-class outcomes. The Company provides a variety of integrated clinical software applications for hospitals, physician practices and post-acute organizations. For hospitals and health systems these applications include its Sunrise Enterprise suite of clinical solutions, comprising a full acute care Electronic Health Record, integrated with financial/administrative solutions including performance management and revenue cycle/access management. The Company's acute care solutions include modules of the Sunrise suite that are available on a stand-alone basis, as well as additional stand-alone solutions including Emergency Department Information System, care management and discharge management. Allscripts IT Outsourcing enables hospitals and physician groups to concentrate on their core mission while using IT to improve clinical, financial and operational outcomes. Allscripts Remote Hosting helps healthcare organizations manage their complex healthcare IT solutions infrastructure while freeing up the physical space, resources and costs associated with maintaining computer servers and deploying client-based applications on-site. The Company also provides a variety of solutions for home care, hospice, skilled nursing, and other post-acute organizations; these range from a fully integrated EHR and financial management solution to Referral Management. Clients in every care setting can leverage Allscripts mobile solutions to deliver remote access to EHR and other capabilities on a wide variety of mobile devices including iPad, iPhone, BlackBerry, Android and Windows Mobile smartphones. Additional add-on applications include its Patient Portal, Patient Kiosk, Prenatal, and Analytics solutions. The Company's community-based solutions for hospitals and health systems, provided in partnership with dbMotion, deliver meaningful health information exchange and enable information connectivity across entire communities of providers, regardless of which technology vendor they use, helping its clients to compete in an evolving marketplace. The Company reports its financial results utilizing three business segments: clinical solutions, hospital solutions and health solutions. The Company's clinical solutions segment presents the operations of its ambulatory solutions for physician practices; hospital solutions reflects the operations, subsequent to the completion of its merger with Eclipsys Corporation on August 24, 2010, of the Company's acute care hospital solutions acquired in the merger; and health solutions reflects the operations of its acute and post-acute solutions for health systems. It has competition from several types of organizations, including providers of practice management solutions, electronic prescribing soluti

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide